Drugmaker Novo Nordisk to slash some insulin prices by 75%
Novo Nordisk, a Danish drugmaker, will cut some insulin prices up to 75% next year, amid pressures from competitors and lawmakers alike.
Novo Nordisk, a Danish drugmaker, will cut some insulin prices up to 75% next year, amid pressures from competitors and lawmakers alike.